<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in the key enzyme of <z:chebi fb="0" ids="26667">sialic acid</z:chebi> biosynthesis, <z:chebi fb="15" ids="17659">UDP</z:chebi>-N-acetylglucosamine 2-epimerase/N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-<z:chebi fb="0" ids="25166">mannosamine</z:chebi> kinase, result in distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> with <z:hpo ids='HP_0003805'>rimmed vacuoles</z:hpo> (DMRV)/hereditary inclusion body <z:hpo ids='HP_0003198'>myopathy</z:hpo> (HIBM) in humans </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="26667">Sialic acid</z:chebi> is an acidic <z:chebi fb="1" ids="35381">monosaccharide</z:chebi> that modifies non-reducing terminal carbohydrate chains on <z:chebi fb="0" ids="17089">glycoproteins</z:chebi> and <z:chebi fb="0" ids="33563">glycolipids</z:chebi>, and it plays an important role in cellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesions</z:e> and interactions </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we generated mice with a V572L point mutation in the GNE kinase domain </plain></SENT>
<SENT sid="3" pm="."><plain>Unexpectedly, these mutant mice had no apparent <z:hpo ids='HP_0003198'>myopathies</z:hpo> or motor dysfunctions </plain></SENT>
<SENT sid="4" pm="."><plain>However, they had a <z:mp ids='MP_0002083'>short lifespan</z:mp> and exhibited <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> with massive <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Histological analysis showed enlarged glomeruli with mesangial matrix deposition, leading to <z:hpo ids='HP_0000096'>glomerulosclerosis</z:hpo> and <z:mp ids='MP_0008059'>abnormal podocyte foot process morphologies</z:mp> in the kidneys </plain></SENT>
<SENT sid="6" pm="."><plain>Glycan analysis using several lectins revealed glomerular epithelial cell hyposialylation, particularly the hyposialylation of podocalyxin, which is one of important molecules for the glomerular filtration barrier </plain></SENT>
<SENT sid="7" pm="."><plain>Administering Neu5Ac to the mutant mice from embryonic stages significantly suppressed the <z:mp ids='MP_0002871'>albuminuria</z:mp> and renal pathology, and partially recovered the glomerular <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> sialylation </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest that the nephrotic-like syndrome observed in these mutant mice resulted from impaired glomerular filtration due to the hyposialylation of podocyte <z:chebi fb="0" ids="17089">glycoproteins</z:chebi>, including podocalyxin </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, it was possible to prevent the nephrotic-like disease in these mice by beginning Neu5Ac treatment during gestation </plain></SENT>
</text></document>